Association of AGTR1 gene A1166C polymorphism with the risk of heart failure: a meta-analysis

Area of Science:

• Genetics
• Cardiovascular Disease
• Molecular Biology

Background:

• The angiotensin II type 1 receptor (AT1R) plays a crucial role in cardiovascular regulation.
• Genetic variations, such as the A1166C polymorphism in the AT1R gene, are investigated for their potential association with disease susceptibility.
• Heart failure (HF) remains a significant global health concern, necessitating the identification of genetic risk factors.

Purpose of the Study:

• To investigate the correlation between the angiotensin II type 1 receptor (AT1R) A1166C gene polymorphism and the risk of developing heart failure (HF).
• To synthesize existing evidence through a meta-analysis to provide a comprehensive assessment of this genetic association.

Main Methods:

• A systematic literature search was conducted on the PubMed database to identify relevant studies.
• Data extraction and quality assessment were performed independently by two reviewers.
• Statistical analysis, including the calculation of odds ratios (ORs) and 95% confidence intervals (CIs), was performed using STATA 12.0 software to evaluate the association under various genetic models (e.g., dominant, recessive) and ethnic subgroups.

Main Results:

• The meta-analysis revealed no statistically significant association between the AT1R A1166C polymorphism and the risk of heart failure across different genetic models (AA vs CC, AA vs AC, dominant, recessive).
• Subgroup analyses based on ethnicity (Caucasian and Asian populations) also indicated a lack of significant association between the A1166C polymorphism and HF susceptibility.
• Specific ORs and 95% CIs were calculated for each comparison, all failing to reach statistical significance.

Conclusions:

• The current meta-analysis suggests that the A1166C polymorphism in the angiotensin II type 1 receptor (AT1R) gene is unlikely to be associated with an increased susceptibility to heart failure.
• The findings indicate that this specific genetic variant may not be a significant risk factor for HF across diverse ethnic groups.
• Larger, well-designed prospective studies are recommended to further validate these findings and definitively establish the role of the AT1R A1166C polymorphism in heart failure pathogenesis.